Literature DB >> 18091558

TAR-DNA binding protein 43 in Pick disease.

Stefanie H Freeman1, Tara Spires-Jones, Bradley T Hyman, John H Growdon, Matthew P Frosch.   

Abstract

Pick disease (PiD) is a frontotemporal dementia characterized by frontal and temporal atrophy, neuronal loss, gliosis, ballooned neurons that are positive for alpha-B crystallin and neurofilament, and the presence of tau- and ubiquitin-positive Pick bodies. TAR-DNA binding protein 43 (TDP-43) has been found to be a component of ubiquitinated inclusions in other neurodegenerative diseases, including frontotemporal lobar degeneration with ubiquitinated inclusions and amyotrophic lateral sclerosis. Fifteen cases of PiD were examined using immunohistochemical methods, and 5 cases with both Pick bodies and smaller intracytoplasmic inclusions that showed staining for ubiquitin, tau, and TDP-43 were observed. The presence of TDP-43 inclusions in PiD suggests that TDP-43 accumulation may be an important component of many neurodegenerative diseases, and that its presence in only some cases of PiD may indicate different pathways of disease development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18091558     DOI: 10.1097/nen.0b013e3181609361

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  31 in total

1.  Disposable immunoplatforms for the simultaneous determination of biomarkers for neurodegenerative disorders using poly(amidoamine) dendrimer/gold nanoparticle nanocomposite.

Authors:  Verónica Serafín; Claudia A Razzino; Maria Gamella; María Pedrero; Eloy Povedano; Ana Montero-Calle; Rodrigo Barderas; Miguel Calero; Anderson O Lobo; Paloma Yáñez-Sedeño; Susana Campuzano; José M Pingarrón
Journal:  Anal Bioanal Chem       Date:  2020-05-30       Impact factor: 4.142

Review 2.  Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

3.  TAR DNA-binding protein-43 in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer disease.

Authors:  Eileen H Bigio
Journal:  Acta Neuropathol       Date:  2008-06-25       Impact factor: 17.088

Review 4.  TDP-43 Prions.

Authors:  Takashi Nonaka; Masato Hasegawa
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

5.  Molecular dissection of TDP-43 proteinopathies.

Authors:  Masato Hasegawa; Takashi Nonaka; Hiroshi Tsuji; Akira Tamaoka; Makiko Yamashita; Fuyuki Kametani; Mari Yoshida; Tetsuaki Arai; Haruhiko Akiyama
Journal:  J Mol Neurosci       Date:  2011-06-16       Impact factor: 3.444

6.  Vulnerability of newly synthesized proteins to proteostasis stress.

Authors:  Guilian Xu; Amrutha Pattamatta; Ryan Hildago; Michael C Pace; Hilda Brown; David R Borchelt
Journal:  J Cell Sci       Date:  2016-03-29       Impact factor: 5.285

Review 7.  The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Ian R A Mackenzie; Rosa Rademakers
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

Review 8.  Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.

Authors:  Felix Geser; Maria Martinez-Lage; Linda K Kwong; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurol       Date:  2009-03-07       Impact factor: 4.849

9.  Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases.

Authors:  A M Isaacs; C Powell; T E Webb; J M Linehan; J Collinge; S Brandner
Journal:  Neuropathol Appl Neurobiol       Date:  2008-08       Impact factor: 8.090

Review 10.  Molecular neuropathology of TDP-43 proteinopathies.

Authors:  Manuela Neumann
Journal:  Int J Mol Sci       Date:  2009-01-09       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.